局部晚期鼻咽癌诱导治疗后容积旋转调强放疗中的解剖与剂量学变化:自适应放疗的意义
回顾性纳入2021年7月至2023年6月60例诱导治疗后行容积旋转调强放疗的局部晚期鼻咽癌患者,基于每周锥形束CT重建的自适应CT比较计划CT与自适应CT的靶区及危及器官体积和剂量变化,发现鼻咽原发灶和颈部淋巴结靶区及腮腺体积缩小、颈部淋巴结靶区剂量下降、腮腺平均剂量升高,初始BMI≥23.5 kg/m2及诱导治疗后未达客观缓解是后期颈部淋巴结靶区剂量下降的危险因素。
要点
- 放疗30次时鼻咽原发灶、颈部淋巴结、同侧及对侧腮腺体积分别较基线缩小2.25%、6.98%、20.09%和18.00%(P<0.001)。
- 25次后颈部淋巴结靶区D99和D95分别较基线下降7.94%和4.18%,同侧及对侧腮腺平均剂量分别升高7.80%和6.50%(P<0.001)。
- 初始BMI≥23.5 kg/m2及诱导治疗后未达客观缓解是后期颈部淋巴结靶区剂量明显下降的危险因素。
核心结论
- 诱导治疗后局部晚期鼻咽癌患者在容积旋转调强放疗25次时重新计划似乎是合理的。
- 初始BMI≥23.5 kg/m2且诱导治疗后未达客观缓解的患者应考虑自适应放疗以稳定递送剂量。
研究设计与样本
- 回顾性纳入2021年7月至2023年6月60例诱导治疗后接受容积旋转调强放疗的局部晚期鼻咽癌患者。
- 基于每周锥形束CT重建的自适应CT用于重新勾画和计划移植,比较计划CT与自适应CT上的体积、Dice相似系数及靶区和危及器官剂量。
- 采用多因素逻辑回归分析危险因素。
主要发现
- 放疗30次时鼻咽原发灶、颈部淋巴结、同侧及对侧腮腺体积分别较基线缩小2.25%、6.98%、20.09%和18.00%(P<0.001)。
- 25次后颈部淋巴结靶区D99和D95分别较基线下降7.94%和4.18%,同侧及对侧腮腺平均剂量分别较基线升高7.80%和6.50%,为剂量学变化峰值速率(P<0.001)。
- 鼻咽原发灶靶区、脑干和脊髓的剂量波动保持在可接受范围内。
- 初始BMI≥23.5 kg/m2及诱导治疗后未达客观缓解被认为是容积旋转调强放疗后期颈部淋巴结靶区剂量明显下降的危险因素。
关键数值与推荐
- 放疗30次时鼻咽原发灶、颈部淋巴结、同侧及对侧腮腺体积分别较基线缩小2.25%、6.98%、20.09%和18.00%(P<0.001)。
- 25次后颈部淋巴结靶区D99和D95分别较基线下降7.94%和4.18%(P<0.001)。
- 25次后同侧及对侧腮腺平均剂量分别较基线升高7.80%和6.50%(P<0.001)。
- 初始BMI≥23.5 kg/m2及诱导治疗后未达客观缓解是容积旋转调强放疗后期颈部淋巴结靶区剂量明显下降的危险因素。
临床怎么用
- 作者认为,诱导治疗后局部晚期鼻咽癌患者在容积旋转调强放疗25次时重新计划似乎是合理的。
- 作者认为,初始BMI≥23.5 kg/m2且诱导治疗后未达客观缓解的患者应考虑自适应放疗以稳定递送剂量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate anatomical and dosimetric changes during volumetric modulated arc therapy (VMAT) in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) after induction therapy (IT) and explore characteristics of patients with notable variations. MATERIALS AND METHODS: From July 2021 to June 2023, 60 LA-NPC patients undergoing VMAT after IT were retrospectively recruited. Adaptive computed tomography (aCT), reconstructed from weekly cone-beam computed tomography(CBCT), facilitates recontouring and planning transplantation. Volume, dice similarity coefficients, and dose to target volumes and organs at risk(OARs) on planning CT(pCT) and aCT were compared to identify changing patterns. Multivariate logistic regression was used to investigate risk factors. RESULTS: The volumes of PGTVnasopharynx (PGTVp), PGTVnode (PGTVn), ipsilateral and contralateral parotid glands decreased during VMAT, with reductions of 2.25 %, 6.98 %, 20.09 % and 18.00 %, respectively, at 30 fractions from baseline (P < 0.001). After 25 fractions, D99 and D95 of PGTVn decreased by 7.94 % and 4.18 % from baseline, respectively, while the Dmean of ipsilateral and contralateral parotid glands increased by 7.80 % and 6.50 %, marking the peak rates of dosimetric variations (P < 0.001). The dosimetric fluctuations in PGTVp, the brainstem, and the spinal cord remained within acceptable limits. Furthermore, an initial BMI ≥ 23.5 kg/m2 and not-achieving objective response (OR) after IT were regarded as risk factors for a remarkable PGTVn dose reduction in the later stages of VMAT. CONCLUSIONS: Replanning for post-IT LA-NPC patients appears reasonable at 25F during VMAT. Patients with an initial BMI ≥ 23.5 kg/m2 and not-achieving OR after IT should be considered for adaptive radiation therapy to stabilize the delivered dose.
引用
- Zhao S, Han J, Yang Z, et al. Anatomical and dosimetric variations during volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma after induction therapy: Implications for adaptive radiation therapy. Clin Transl Radiat Oncol. 2024. PMID: 39381630. doi:10.1016/j.ctro.2024.100861
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。